Software & SaaS

Flag Ship Acquisition inks a letter of intent with financial services firm Bluechip, a key test for the recovering but still-cautious SPAC market.

The Patrouille de France returns to the U.S. for the first time in nearly a decade, launching a tour celebrating 250 years of Franco-American alliance.

With 34 years in finance, John Asta brings a behavioral-focused practice to Missouri City, leveraging Gateway Financial Partners' support ecosystem.

A new partnership between yieldWerx and WATS promises to unify fragmented manufacturing data, revolutionizing quality control for complex electronics.

Butterfly Network adds B. Braun veteran Caroll Neubauer to its board, a strategic move to leverage his global scaling and policy expertise for growth.

Continuum AI launches a free, open-source router for 200+ models, betting its future not on tolls but on enterprise-grade control and governance.

A new AI from a Nobel laureate-led team claims to predict geopolitical crises. But can we trust a machine with the future of global security?

The Ethical AI Governance Group expands to Europe, appointing new leadership and forging global alliances to move AI from experimentation to responsible adoption.

By acquiring Sphere's proven methodology, Startup Science aims to give every founder the structured guidance once reserved for elite accelerator programs.

After a 32% revenue surge, GigaCloud's CEO will detail the company's next moves at the Needham conference. Investors are watching for growth signals.

Dr. Amanda Wilson's appointment to a powerful D.C. council puts her tech-driven addiction treatment model in the national policy spotlight.

AiTradeBtc's new platform targets institutional investors with AI-driven stability, but a lack of independent verification raises critical questions.

Scooter giant Lime files for a landmark IPO, but its S-1 reveals massive debt, setting up a crucial test for the future of urban transport.

Online lender Loanz pivots from a tough US market to focus on Canada, deploying AI to serve a growing number of underserved Canadian borrowers.

An innovative RNA-editing therapy for hepatocellular carcinoma has received a major FDA designation, potentially accelerating its path to patients.

A new fund, NICO, challenges ESG norms by investing in tobacco giants, aiming to force a shift to safer products. Can engagement succeed where exclusion has failed?

SimScale has launched Engineering AI agents that automate entire simulation workflows, promising to eliminate bottlenecks and slash design cycles from months to hours.

A three-month FDA delay for a new LEQEMBI injection highlights the high-stakes race for a convenient Alzheimer's therapy and its complex safety hurdles.

A KIST-led delegation of Korean quantum startups partners with IBM, signaling a major push to commercialize deep tech on the global stage.

Avnet's new integration facility in Singapore is more than a building; it's a strategic move in the global shift to diversify tech supply chains beyond China.